Takeda and Weave Bio collaborate on AI-driven automation in drug development
Pharmaceutical Technology
Takeda has entered into a collaboration to introduce Weave Bio's AI-native regulatory automation platform across 14 ongoing drug development programmes in various global markets.
pharminent
September 2, 2026 (Last updated: September 2, 2026)
Pharmaceutical Technology
Takeda has entered into a collaboration to introduce Weave Bio’s AI-native regulatory automation platform across 14 ongoing drug development programmes in various global markets.